Sign In
to Vote &
Create Storyboards.
 
Bristol-Myers Squibb's stock has inched up a little following its Q1 2017 earnings release last week, as the company reported better than expected results.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard